Literature DB >> 36175816

High Incidence, Reinfections, and Active Syphilis in Populations Attending a Specialized HIV Clinic in Mexico, a Dynamic Cohort Study.

Omar David Tumalán-Gil1, Verónica Ruiz-González2, Santa García-Cisneros1, Andrea González-Rodríguez3, Antonia Herrera-Ortiz1, Maria Olamendi-Portugal1, Miguel Angel Sánchez-Alemán4.   

Abstract

Syphilis, a sexually transmitted infection, has reemerged in many vulnerable groups around the world. The objective of the current study was to determine the prevalence and incidence of syphilis among people who attended a specialized HIV clinic in Mexico from 2011 to 2015. Databases from the laboratory were analyzed, and the following four groups were formed: people seeking HIV-1 voluntary counseling and testing (VCT), people in prison (PPr), people living with HIV (PLWH), and patients from primary care clinics (others). The diagnosis of syphilis was made using the reverse algorithm; antibody titers were examined to determine the stage of infection. Baseline data were analyzed and, with follow-up information, a retrospective dynamic cohort was formed. Factors associated with the seroprevalence of syphilis and active syphilis were evaluated by the chi-square test. Moreover, risk factors for the incidence of syphilis were described. A total of 81,863 baseline individuals were analyzed. The seroprevalence of syphilis was 9.9% in the VCT group, 8.2% in the PPr group, 37.0% in the PLWH group, and 8.7% in the others group; the prevalence of active syphilis was 1.7-13.1%. A total of 11,124 people were followed up. The incidence (cases per 100 person-years) was 3.5 among the VCT group, 16.0 among the PLWH group, and < 0.1 among both the PPr and others groups, respectively; moreover, the frequency of reinfections was 11.1-24.4%. The high prevalence and incidence of syphilis, active syphilis, and reinfections among men, transgender people, individuals aged 20-39 years, and people with a history of HIV or hepatitis B suggest that it is critical to improve prevention, diagnosis, and treatment measures to stop the reemergence of syphilis. There are also new factors such as methamphetamine use, group sex, or contacting partners over the internet that are associated with syphilis. In addition, HIV preexposure prophylaxis could contribute to the increased incidence of syphilis by providing false security in the prevention of STIs, thereby increasing risky sexual behaviors.
© 2022. The Author(s).

Entities:  

Keywords:  Cohort studies; HIV; Incidence; Sexually transmitted infections; Syphilis; Syphilis serodiagnosis

Year:  2022        PMID: 36175816     DOI: 10.1007/s10508-022-02433-1

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  23 in total

Review 1.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

2.  Very high incidence of syphilis in HIV-infected men who have sex with men in Buenos Aires city: a retrospective cohort study.

Authors:  E Bissio; V Cisneros; G D Lopardo; L I Cassetti
Journal:  Sex Transm Infect       Date:  2016-11-17       Impact factor: 3.519

3.  Sexual network characteristics of men who have sex with men with syphilis and/or gonorrhoea/chlamydia in Lima, Peru: network patterns as roadmaps for STI prevention interventions.

Authors:  Cherie Blair; Ryan Colby Passaro; Eddy R Segura; Jordan E Lake; Amaya G Perez-Brumer; Jorge Sanchez; Javier R Lama; Jesse L Clark
Journal:  Sex Transm Infect       Date:  2019-04-22       Impact factor: 3.519

4.  Repeat syphilis among men who have sex with men in California, 2002-2006: implications for syphilis elimination efforts.

Authors:  Stephanie E Cohen; Rilene A Chew Ng; Kenneth A Katz; Kyle T Bernstein; Michael C Samuel; Peter R Kerndt; Gail Bolan
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

5.  Increasing incidence rates of sexually transmitted infections from 2010 to 2019: an analysis of temporal trends by geographical regions and age groups from the 2019 Global Burden of Disease Study.

Authors:  Min Du; Wenxin Yan; Wenzhan Jing; Chenyuan Qin; Qiao Liu; Min Liu; Jue Liu
Journal:  BMC Infect Dis       Date:  2022-06-26       Impact factor: 3.667

6.  Incidence and Predictors of HIV and Sexually Transmitted Infections Among Female Sex Workers and Their Intimate Male Partners in Northern Mexico: A Longitudinal, Multilevel Study.

Authors:  Angela Robertson Bazzi; Gudelia Rangel; Gustavo Martinez; Monica D Ulibarri; Jennifer L Syvertsen; Samuel A Bazzi; Scott Roesch; Heather A Pines; Steffanie A Strathdee
Journal:  Am J Epidemiol       Date:  2015-03-13       Impact factor: 4.897

7.  Syphilis and HIV co-infection in patients who attend an AIDS outpatient clinic in Vitoria, Brazil.

Authors:  Fabiola Mesquita Callegari; Lauro Ferreira Pinto-Neto; Charlla Jezus Medeiros; Camila Binsi Scopel; Kimberly Page; Angélica Espinosa Miranda
Journal:  AIDS Behav       Date:  2014-01

8.  A Cross-Sectional Study of Prisoners in Mexico City Comparing Prevalence of Transmissible Infections and Chronic Diseases with That in the General Population.

Authors:  Sergio Bautista-Arredondo; Andrea González; Edson Servan-Mori; Fenella Beynon; Luis Juarez-Figueroa; Carlos J Conde-Glez; Nathalie Gras; Juan Sierra-Madero; Ruy Lopez-Ridaura; Patricia Volkow; Stefano M Bertozzi
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

9.  Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men.

Authors:  Sergio Bautista-Arredondo; M Arantxa Colchero; Martín Romero; Carlos J Conde-Glez; Sandra G Sosa-Rubí
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

10.  Incidence of syphilis among HIV-infected men in Singapore, 2006-2017: temporal trends and associated risk factors.

Authors:  Li Wei Ang; Chen Seong Wong; Oon Tek Ng; Yee Sin Leo
Journal:  Sex Transm Infect       Date:  2019-08-01       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.